PMA P130021S109

Device
Medtronic CoreValve Evolut R System, Medtronic CoreValve Evolut PRO System, Medtronic Evolut PRO+ System, Medtronic Evol
Applicant
Medtronic, Inc.
Product code
NPT
Decision date
2022-04-29
Generic name
Aortic valve, prosthesis, percutaneously delivered
Approval order statement
Approval for 1) modifications to the Medtronic Evolut FX Instructions for Use to include the clinical data; and 2) reformatting the clinical study summaries and revising the legal manufacturer address in the IFUs for the Evolut R, Evolut PRO, Evolut PRO+, and Evolut FX Systems.

Current openFDA PMA Record#

Device
Medtronic CoreValve Evolut R System, Medtronic CoreValve Evolut PRO System, Medtronic Evolut PRO+ System, Medtronic Evol
Applicant
Medtronic, Inc.
PMA number
P130021
Supplement
S109
Product code
NPT
Generic name
Aortic valve, prosthesis, percutaneously delivered
Decision date
2022-04-29
Decision code
APPR
Date received
2022-01-28
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for 1) modifications to the Medtronic Evolut FX Instructions for Use to include the clinical data; and 2) reformatting the clinical study summaries and revising the legal manufacturer address in the IFUs for the Evolut R, Evolut PRO, Evolut PRO+, and Evolut FX Systems.